IRDAI's Suitability Shift in 2026: What Commercial Brokers Should Document Now

For most of the last decade, an Indian commercial insurance buyer who felt mis-sold a policy carried the burden of proof. The buyer had to demonstrate that the broker had misrepresented cover, omitted a material clause, or failed to disclose an exclusion. The regulator could intervene, but only after the buyer had built a case.

That allocation of burden is changing. The IRDAI's rule-making direction since 2023, taken together with the Bima Sugam transparency architecture and the Expenses of Management (EOM) Regulations, 2024, points to a documented-suitability regime where the seller, not the buyer, must show that the recommendation was appropriate. In retail life and health, this shift is already visible in the IRDAI Master Circular on Corporate Agents, 2024, which requires a written needs analysis retained for the policy term plus 5 years.

Commercial insurance brokers have so far been treated as a sophisticated channel selling to sophisticated buyers. That assumption is wearing thin. Mid-market industrial buyers, professional service firms, and SMEs are not the same as a Fortune 500 risk manager, and regulators are starting to say so. The IRDAI (Insurance Brokers) Regulations, 2018 already impose a fiduciary duty on brokers towards their clients, and the 2024 consultation paper on distribution standards proposed US/UK-style documented suitability obligations that would extend across the channel. Brokers should restructure placement workflow now, before the rule lands, because the muscle memory takes years to build. See the hub: commercial mis-selling guide for the wider context.

The regulatory trajectory is clearest when laid out chronologically. Each item below is in force today.

• 2017: IRDAI (Protection of Policyholders' Interests) Regulations. Codified the free-look period, the prospectus disclosure standards, and the duty of insurers to deal fairly with policyholders. Foundation document for any mis-selling discussion.
• 2018: IRDAI (Insurance Brokers) Regulations. Imposed a fiduciary duty of care on brokers, with a written Code of Conduct in Schedule I that obliges the broker to act in the client's interest, disclose conflicts, and recommend cover suited to the client's needs.
• 2023: RBI Master Direction on Customer Service in Banks. Not directly binding on brokers, but it set the tone for cross-regulator alignment on suitability and informed choice in financial-product distribution.
• 2024: IRDAI Master Circular on Corporate Agents. Tightened suitability disclosure, documented needs analysis, and record retention. The model for what is likely to follow for brokers.
• 2024: IRDAI (Expenses of Management) Regulations. Capped distribution costs across the insurer and forced commission structures into the open.
• 2024: IRDAI Master Circular on Remuneration. Realigned the commission ceiling and reporting framework, with explicit linkage to mis-selling risk.
• 2024: IRDAI consultation paper on distribution standards. Floated US/UK-style documented suitability obligations across distribution channels including brokers.
• May 2026: Bima Sugam first commercial use case launch. Wholesale and SME-segment transparency arrives.
• 2026 IRDAI updates: board-approved solicitation policy, annual conduct audit, and written commission policy required by registered intermediaries.

Three of these moves (Corporate Agents Master Circular, EOM Regulations, and the 2024 consultation) make the direction unambiguous. Brokers selling to commercial buyers are next in line.

Bima Sugam is not a regulatory rule. It is an infrastructure layer, but its conduct effects are larger than most rules. When commercial buyers can see indicative quotations, standard wordings, and comparable cover structures on a regulator-backed platform, the broker's room to over-promise narrows quickly.

The first commercial use case launches in May 2026, beginning with mid-market property and SME packages, and is expected to widen to liability lines through 2026 and into 2027. Two conduct consequences follow.

First, opacity becomes a liability. If a Sugam-listed product offers comparable cover at a lower premium, the broker who placed an off-platform alternative must show why. The reasoning may be perfectly sound, perhaps the buyer needed a manuscript wording, or the listed product carried an exclusion the buyer could not accept, but the reasoning must be documented at the point of placement. Reconstructing it after a claim dispute is too late.

Second, the comparison record becomes regulatory evidence. A broker who approached three insurers but documented only the placed quotation has a weaker position than one who recorded all three including the declined options and the reasoning. This is consistent with the Bima Sugam playbook framing of the platform as a discipline mechanism, not just a distribution channel.

The practical implication is that placement records need to be Sugam-comparable: same risk description, same indicative sum insured, same primary clauses. Brokers who treat each placement as a one-off conversation will struggle to produce the comparison trail a future regulator may request.

The IRDAI (Expenses of Management) Regulations, 2024, together with the same year's Master Circular on Remuneration, did something subtle. By capping aggregate distribution costs at the insurer level and forcing written commission policies on intermediaries, they removed much of the room for ad-hoc commission negotiation that historically distorted broker incentives.

In the previous regime, two brokers approaching the same insurer for the same risk could receive materially different commissions based on relationship, volume, or negotiation. The buyer rarely saw the difference, and the broker's recommendation could be tilted towards the insurer offering the better commission rather than the better cover. The 2024 framework does not eliminate this, but it makes the commission flow visible to the buyer and to the IRDAI in a way that did not exist before. See the deeper analysis at IRDAI brokerage commission reforms.

Why this matters for suitability documentation: once commission flows are transparent, any deviation from the apparent best-cover recommendation must be defensible on grounds other than commission. The broker who placed with Insurer B at a higher premium and lower cover than Insurer A's quotation will need a written reason, signed off at placement.

A related move is the 2026 expectation that intermediaries maintain a board-approved solicitation policy, conduct an annual audit, and adopt a written commission policy. Together, these convert what was tacit broker discretion into auditable broker process. The mis-selling risk does not disappear; it becomes documentable, which is both a protection for the diligent broker and an exposure for the casual one.

The single highest-leverage move for a commercial broker in 2026 is to standardise six documentation habits across every placement. None of them are exotic. All of them produce a defensible record that protects the broker, the client, and the relationship.

1. Client risk profile signed off at quotation stage. A one-page profile capturing industry, key exposures (property values, headcount, liability footprint, professional indemnity context), indicative sums insured, and material claims history. Signed by the client before the broker approaches the market. This anchors every later conversation.

2. Insurer comparison record. A written log of which insurers were approached, who quoted, who declined, and the reasoning for each. If the broker placed with Insurer C rather than Insurer A's lower quote, the reasoning sits in this record (Insurer A's exclusions, Insurer C's claims service, the buyer's choice).

3. Cover recommendation with reasoning. Why this LOB mix, this sum insured, these clauses. Particularly important for under-insurance avoidance, which we covered in the companion: under-insurance is mis-selling post. A recommendation note dated at placement is far stronger evidence than a reconstructed rationale after a claim.

4. Under-insurance and gap notes raised with client in writing. When the broker spots a gap (no business interruption, low D&O limit relative to peer comparables, no cyber cover for an IT-heavy buyer), it must be raised in writing and the client's response recorded. Silence on a gap is not safer for the broker; it is far more dangerous.

5. Renewal review. At renewal, re-examine the risk profile against the prior-year placement. Has the headcount changed, the asset base grown, the operations expanded? The renewal note records what changed and how the cover was adjusted.

6. Tenant-isolated retention for 5+ years. Aligned with the Master Circular on Corporate Agents, 2024 expectation of policy-term-plus-5-years for retail. Commercial brokers should not assume the standard is lower for them.

Mature markets have walked this road already, and the pattern is consistent. When a regulator tightens conduct obligations and the cost of undocumented advice rises, two things follow: large remediation bills for legacy mis-selling and a permanent restructure of how distribution documents itself.

The UK Financial Conduct Authority's Treating Customers Fairly framework, followed by the Payment Protection Insurance remediation programme that ran from 2011 onwards, produced over GBP 38 billion (approximately Rs 38 lakh crore equivalent) in compensation payouts. The defining feature of PPI was not malice; it was undocumented advice at scale. Brokers and bancassurance sellers could not show, retrospectively, why a given customer had bought a given product. The absence of contemporary records made every complaint resolvable only in the customer's favour.

The Australian Royal Commission into Misconduct in the Banking, Superannuation and Financial Services Industry, which ran from 2017 to 2019, found similar patterns. Distribution practices that looked acceptable at the time of sale looked indefensible when read against a documented-suitability standard applied retrospectively. The cost was measured in fines, restitution, and the wholesale exit of major banks from financial advice as a line of business.

The US debate played out differently, with the SEC's Regulation Best Interest finalised in 2020 sitting alongside the Department of Labor's earlier (and ultimately vacated) fiduciary rule. The fault line was between suitability (the cheaper, weaker standard) and fiduciary (the costlier, stronger standard). Reg BI settled on documented best-interest with explicit disclosure obligations, but the direction of travel remains towards more documentation, not less. See also the bancassurance conduct discussion for the Indian analogue developing in retail.

The lesson for Indian commercial brokers is direct. Whether the formal standard arrives as suitability, best-interest, or something Indian-specific, the documentation burden will be retrospective. The placements being done today will be assessed against tomorrow's rule, applied to today's records. Brokers who already document well will be unaffected. Brokers who do not will be exposed to liability they cannot defend after the fact.